- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.57 Å
- Oligo State
- homo-dimer
- Ligands
- 7 x GLC- FRU: beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose(Non-covalent)
- 3 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
1PE.8: 12 residues within 4Å:- Chain A: F.168, I.218, M.279, G.282, E.283, L.286, T.353, G.355, S.357, Q.361, M.362
- Ligands: 01.16
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.357
1PE.9: 3 residues within 4Å:- Chain A: A.188, W.189, K.192
No protein-ligand interaction detected (PLIP)1PE.10: 7 residues within 4Å:- Chain A: V.426, D.427, S.428, G.429, A.453, G.454, L.455
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.427, A:G.454
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.11: 5 residues within 4Å:- Chain A: E.92, L.93, R.117, I.506, P.507
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.92
- Salt bridges: A:R.117, A:R.510
SO4.12: 6 residues within 4Å:- Chain A: V.157, T.158, T.159, G.160, G.485, H.486
3 PLIP interactions:3 interactions with chain A- Water bridges: A:D.487, A:D.487
- Salt bridges: A:H.486
SO4.13: 2 residues within 4Å:- Chain A: T.492, L.493
No protein-ligand interaction detected (PLIP)SO4.14: 4 residues within 4Å:- Chain A: P.507, P.508, T.509, R.510
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.510
SO4.15: 3 residues within 4Å:- Chain A: Y.203, E.219, T.220
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.219
- Water bridges: A:T.220
SO4.17: 3 residues within 4Å:- Chain B: R.117, N.118, K.512
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.118, B:N.118
- Water bridges: B:K.512
- Salt bridges: B:K.512
SO4.18: 2 residues within 4Å:- Chain B: N.439, R.466
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.439
- Salt bridges: B:R.466
SO4.19: 3 residues within 4Å:- Chain B: Y.203, E.219, T.220
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.219
- 1 x 01: N-(1-{3,5-difluoro-4-[(4-{[fluorodi(hydroxy)-lambda~4~-sulfanyl]oxy}phenoxy)methyl]phenyl}-1H-1,2,4-triazol-3-yl)methanesulfonamide
01.16: 19 residues within 4Å:- Chain A: F.168, Q.249, S.250, R.275, M.279, M.294, L.296, V.318, A.320, Q.324, V.326, F.347, R.349, F.351, S.357, H.358, V.441, Q.445
- Ligands: 1PE.8
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.168, A:L.296, A:V.318, A:F.351
- Hydrogen bonds: A:Q.324, A:R.349, A:S.357
- pi-Stacking: A:F.168
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Krieger, I.K. et al., A SuFEx-based TB clinical candidate irreversibly inhibits Pks13. To Be Published
- Release Date
- 2025-05-07
- Peptides
- Polyketide synthase Pks13: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.57 Å
- Oligo State
- homo-dimer
- Ligands
- 7 x GLC- FRU: beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose(Non-covalent)
- 3 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 1 x 01: N-(1-{3,5-difluoro-4-[(4-{[fluorodi(hydroxy)-lambda~4~-sulfanyl]oxy}phenoxy)methyl]phenyl}-1H-1,2,4-triazol-3-yl)methanesulfonamide
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Krieger, I.K. et al., A SuFEx-based TB clinical candidate irreversibly inhibits Pks13. To Be Published
- Release Date
- 2025-05-07
- Peptides
- Polyketide synthase Pks13: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B